Literature DB >> 1419951

Hodgkin's disease derived cell lines: a review.

H G Drexler1, J Minowada.   

Abstract

A number of so-called "HD cell lines" have been established over the last 10-15 years (Table 1). Or those 15 cell lines we studied, only the cell lines CO, DEV, HD-70, HDLM, KM-H2, L-428, L-540 and SUP-HD1 can be regarded to represent true HD cell lines. According to the immunostaining results and molecular genetic data, these 8 cell lines can be assigned either to the T-cell lineage (CO, HDLM, L-540) or B-cell lineage (DEV, HD-70, KM-H2, SUP-HD1). With the data currently available, the cell lineage origin of L-428 cannot be unequivocally determined, but appears to be lymphoid. All but one of these eight HD cell lines have been established from patients with the nodular sclerosis subtype. Therefore, the conclusions drawn from the in vitro studies are limited to this histological subtype of HD. It is conceivable that culture conditions select for a particular type of cell that will survive. The state of differentiation of these HD cell lines remains unclear due to the incomplete expression of T- or B-cell antigens. The in vitro cells and the in vivo H-RS cells share, however, the expression of the unique activation markers CD15, CD25, CD30, CD71 and HLA-DR. Recently published data indicate that the HD cell lines express and produce a large number of cytokines. Multiple non-random chromosomal abnormalities and the expression of various proto-oncogenes are also new and exciting findings and certainly deserve further study. In summary, although the cultured cells are not unequivocally proven to be the direct progeny of in vivo H-RS cells, several continuous HD cell lines have been established that display a variety of phenotypical features identical or similar to those of their presumed in vivo counterparts. Surface marker, molecular genetic and other features suggest a T- or B-cell derivation. An extrapolation of these conclusions would point to a lymphoid origin of H-RS cells. Whether H-RS cells can originate from other cell types such as monocytes/macrophages or reticulum cells, cannot be answered with the currently available HD cell lines.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1419951

Source DB:  PubMed          Journal:  Hum Cell        ISSN: 0914-7470            Impact factor:   4.174


  7 in total

1.  Circulating clonotypic B cells in classic Hodgkin lymphoma.

Authors:  Richard J Jones; Christopher D Gocke; Yvette L Kasamon; Carole B Miller; Brandy Perkins; James P Barber; Milada S Vala; Jonathan M Gerber; Lan L Gellert; Mark Siedner; M Victor Lemas; Sarah Brennan; Richard F Ambinder; William Matsui
Journal:  Blood       Date:  2009-02-02       Impact factor: 22.113

2.  A short treatise concerning a musical approach for the interpretation of gene expression data.

Authors:  Martin S Staege
Journal:  Sci Rep       Date:  2015-10-16       Impact factor: 4.379

3.  Knock-down of PRAME increases retinoic acid signaling and cytotoxic drug sensitivity of Hodgkin lymphoma cells.

Authors:  Stefanie Kewitz; Martin S Staege
Journal:  PLoS One       Date:  2013-02-11       Impact factor: 3.240

4.  Expression and Regulation of the Endogenous Retrovirus 3 in Hodgkin's Lymphoma Cells.

Authors:  Stefanie Kewitz; Martin Sebastian Staege
Journal:  Front Oncol       Date:  2013-07-10       Impact factor: 6.244

Review 5.  Curcuma Contra Cancer? Curcumin and Hodgkin's Lymphoma.

Authors:  Stefanie Kewitz; Ines Volkmer; Martin S Staege
Journal:  Cancer Growth Metastasis       Date:  2013-08-08

Review 6.  Chromosomal Instability in Hodgkin Lymphoma: An In-Depth Review and Perspectives.

Authors:  Corina Cuceu; William M Hempel; Laure Sabatier; Jacques Bosq; Patrice Carde; Radhia M'kacher
Journal:  Cancers (Basel)       Date:  2018-03-26       Impact factor: 6.639

7.  Cisplatin-Based Chemotherapy of Human Cancers.

Authors:  Andrea Brown; Sanjay Kumar; Paul B Tchounwou
Journal:  J Cancer Sci Ther       Date:  2019-04-08
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.